MedTrace Logo

In'Oss™ (MBCP® Putty) Ortho

NCT06326827 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-02-05

No results posted yet for this study

Summary

Study of the osteoconductive potential of the injectable bone substitute In'Oss™ (MBCP® Putty) in the filling of orthopaedic bone defects to collect Post-Market Clinical Follow-up (PMCF) data for the CE-marked In'Oss™ (MBCP® Putty) device in the orthopaedic trauma surgery

Conditions

  • Orthopedic Disorder
  • Trauma Injury
  • Extremity Injury

Interventions

DEVICE

In'Oss™ (MBCP® Putty)

Use of In'Oss™ (MBCP® Putty) in surgical procedure to correct epiphyso-metaphyseal and/or metaphyso-diaphyseal bone defect in one of the following anatomical locations: Proximal humerus, Distal radius, Distal femur, Proximal tibia, Distal tibia.

Sponsors & Collaborators

  • Advanced Medical Solutions Ltd.

    lead INDUSTRY

Principal Investigators

  • Peter Giannoudis · Leeds General Infirmary, Great George Street Leeds LS1 3EX, United Kingdom

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2027-03-31
Completion
2027-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06326827 on ClinicalTrials.gov